Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer
Recruiting · NCT06568679 · Observational (researchers observe without assigning treatment) · Lead sponsor: The Netherlands Cancer Institute
View the official record on ClinicalTrials.gov →Interventions studied
No intervention; observational
What this trial is about
The study aims to collect high quality clinical data on lifestyle and patient biomaterials prior to start or during / after treatment of early-onset colorectal cancer (EOCRC) and to inform on treatment and survival outcomes of EOCRC patients.
Who can take part
Age range
18 Years to 49 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with locoregional or metastatic colorectal cancer (CRC)
- Histologically proven CRC
- Age 18 - 49 years at time of first CRC diagnosis
- Able to understand the informed consent form
- Provide written informed consent.
Exclusion criteria
- Mentally incompetent patients based on the opinion of treating physician
- Inability to understand the Dutch language
Where it is running
1 location listed.
- Netherlands Cancer Institute - Amsterdam, North Holland, Netherlands